Cargando…
Is antenatal RhIg completely safe?
Autores principales: | Subramaniyan, Rajeswari, Pereira, Karishma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877609/ https://www.ncbi.nlm.nih.gov/pubmed/27208576 http://dx.doi.org/10.1016/j.bjhh.2016.01.006 |
Ejemplares similares
-
Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti‐D was incorrectly identified as RhIG
por: Walhof, Mackenzie L., et al.
Publicado: (2022) -
Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study
por: Slootweg, Y. M., et al.
Publicado: (2022) -
Non-RhD (anti-E) red cell alloimmunization following platelet transfusion: a case report and implications on quality of the platelet concentrates and antibody screening protocols
por: Subramaniyan, Rajeswari
Publicado: (2022) -
Role of daratumumab in transfusion medicine: a must know entity
por: Subramaniyan, Rajeswari, et al.
Publicado: (2017) -
Diminished expression of B antigen mimicking B3 phenotype in a patient with AML-M3: a rare case report
por: Subramaniyan, Rajeswari
Publicado: (2016)